GÖRG advises SIT Skin Investigation and Technology Hamburg GmbH in context with the takeover by SGS INSTITUT FRESENIUS GmbH

05.04.2018

[Hamburg, ] A GÖRG team led by Associated Partner Dr. John-Patrick Bischoff has advised the shareholders of the Hamburg based SIT Skin Investigation and Technology Hamburg GmbH on the sale of all shares to SGS INSTITUT FRESENIUS GmbH. With the acquisition of SIT Skin Investigation and Technology Hamburg GmbH the SGS-group expands its consumer and retail service portfolio into the testing sector for skin care. The parties have agreed not to disclose the purchase price or details concerning the transaction.

About SIT Skin Investigation and Technology Hamburg GmbH

SIT Skin Investigation and Technology Hamburg GmbH is one of the leading independent contract research companies in Germany providing applied dermatological research and studies for the cosmetics and personal care industries. The international company was incorporated 1997 and offers a broad range of skin tolerance and proof of efficacy testing.

About SGS INSTITUT FRESENIUS GmbH

SGS INSTITUT FRESENIUS GmbH with seat in Taunusstein is one of Europe's leading providers of non-medical laboratory analysis. The competence of SGS INSTITUT FRESENIUS GmbH can be seen in more than 150 certifications, accreditations and approvals and in 155 years of experience in the field of analytics. SGS INSTITUT FRESENIUS GmbH is part of the SGS-group, the world’s leading inspection, verification, testing and certification company. With more than 95,000 employees, SGS-group operates a network of over 2,400 offices and laboratories around the world.

Advisors

GÖRG Partnerschaft von Rechtsanwälten mbB
Dr. John-Patrick Bischoff, LL.M., Associated Partner, M&A / Healthcare, Hamburg
Dr. Jan-Henric M. Punte, LL.M., Associate, M&A / Gesellschaftsrecht, Hamburg
Dr. Marc Schüffner, Partner, Public Commerical Law / Healthcare, Berlin

GÖRG Newsletter

We inform you about current legal developments in the areas that are relevant to you.

Please subscribe to receive our newsletter.

We're using cookies to statistically monitor the usage of our website.

OK Deny tracking Privacy policy